Abstract
From October 1976 to May, 1990, a total of 86 patients with stage IV (TNM) gallbladder cancer were treated at Tsukuba University Hospital. Twenty-seven of the 86 patients underwent tumor resection; 43 patients received palliative surgery. The remaining 16 were too advanced to have surgery. Of 27 patients who had tumor resection, 9 had resection alone, 17 had intraoperative radiation therapy (IORT)±postoperative external radiotherapy (ERT), and 1 had postoperative ERT.
The procedures used were: extended right hepatic lobectomy plus hepaticobiliary resection (HBR) (n=2), hepatic segmentectomy (SIVb, SV) plus HBR (n=9), hepatic segmentectomy (SIV, V, VI) with HBR (n =1), hepatic segmentectomy (SIV, V) plus HBR with pancreaticoduodenectomy (PD) (n=3), PD plus HBR (n=1), cholecystectomy with wedge resection of the gallbladder fossa plus HBR (n=3), and cholecystectomy plus HBR (n=3), and cholecystectomy (n=4). Regional lymph node dissections were performed in every patient and 17 of 27 patients underwent additional resections of adjacent organs such as the stomach, duodenum, colon, and abdominal wall.
A single dose of 20–30 Gy was delivered intraoperatively for 17 patients. A mean total dose of 36.4 Gy (1.8/fraction) was added to IORT for 10 patients.
The three-year cumulative survival rate was 10.1% for resection plus IORT but 0% for resection alone. The longest survivor is alive and well at 3 years and 3 patients are alive 16,13, and 4 months after tumor resection followed by IORT plus ERT.
Résumé
Entre octobre 1976 et mai 1990, 86 patients ayant un cancer de la vésicule de stade IV (TNM) ont été traités à l'hôpital universitaire Tsukuba. Parmi ces 86 patients, 27 ont eu une résection de leur tumeur et 43 une chirurgie palliative. Les 16 autres cancers étaient trop avancés pour être opérés. Sur les 27 patients qui ont eu une résection de leur tumeur, 9 ont eu une résection seule, 17 ont reçu une irradiation peropératoire (IP) avec ou sans une radiothérapie externe postopératoire (REP) et un patient a reçu une REP postopératoire.
Les différents procédés chirurgicaux étaient les suivants: hépatectomie gauche avec résection hépaticocholédocienne (RHC) (n=2), segmentectomie (IVb, V) avec RHC (n=9), segmentectomie (IV, V, VI) with RHC (n=1), segmentectomie (IV, V) avic RHC et duodénopancréatectomie céphalique (DPC) (n=3), DPC et RHC (n=1), cholécystectomie avec résection du lit vésiculaire à la demande et RHC (n=3), cholécystectomie et RHC (n=3), et cholécystectomie (n=4). Une lymphadénectomie régionale a été effectuée chez tous les patients et sur les 27, 17 ont eu une résection étendue aux organes adjacents: estomac, duodénum, côlon et paroi abdominale.
Vingt à 30 Gy ont été administrés en une seule fois en peropératoire chez 17 patients. Une dose moyenne de 36.4 Gy (1.8/fr.) a été ajoutée à l'IP chez 10 patients.
Le taux de survie actuarielle était de 10.1% pour les résections avec IP mais était de 0% pour les résections seules. Le plus vieux survivant est sans maladie à 3 ans et 3 patients sont vivants depuis 16, 13, et 4 mois après résection de la tumeur suivie d'IP et de REP.
Resumen
Ochenta y seis pacientes con cáncer de la vesícula biliar en estado IV (TNM) fueron tratados en el Hospital de la Universidad de Tsukuba entre octubre de 1976 y mayo de 1990; 27 de los 86 fueron sometidos a resección del tumor y 43 a cirugía paliativa, mientras los 16 restantes se encontraron en estado demasiado avannzado para consideración quirúrgica. De los 27 pacientes sometidos a resección del tumor, 9 tuvieron resección solamente, 17 tuvieron irradiación intraoperatoria (TIIOP)±radioterapia extrena postoperatoria (RTE), y uno tuvo RTE postoperatoria.
Los procedimientos operatorios utilizados fueron los siguientes: lobectomía hepática derecha amplia más resección hepaticocoledociana (RHC) (n=2), segmentectomía hepática (SIVb, SV) más RHC (n=9), segmentectomía hepática (SIV, V, VI) con RHC (n=1), segmentectomía hepática (SIV, V) más RHC con pancreaticoduodenectomía (PD) (n=3), PD más RHC (n=1), colecistectomía con resección de la fosa de la vesícula biliar más RHC (n=3), colecistectomía + RHC (n= 3), y colecistecomía (n=4). Se efectuó disección regional de los ganglios linfáticos en todos los pacientes y 17 de 27 pacientes fueron sometidos a la resección adicional de órganos adyacentes taies como el estómago, duodeno, colon, y pared abdominal.
Una dosis única de 20–30 Gy fue administrada intraoperatoriamente en 17 pacientes. Una dosis total promedio de 36.4 Gy (1.8/fr.) fue añadida a la TIIOP en 10 pacientes.
La tasa de sobrevida acumulada a 3 años fue 10.1% para los pacientes con resección y TIIOP, pero fue de 0% para los pacientes con resección solamente. El paciente de mayor sobrevida está bien a 3 años y 3 se encuentran vivos a 16, 13, y 4 meses después de la resección del tumor seguida de TIIOP más RTE.
Similar content being viewed by others
References
Hermanek, P., Sobin, L.H.: TNM Classification of Malignant Tumours, 4th edition, Berlin, Spinger-Verlag, 1987, pp. 56–58
White, K., Kraybill, W.G., Lopez, M.J.: Primary carcinoma of the gallbladder; TNM staging and prognosis. J. Surg. Oncol.39:251, 1988
Morrow, C.E., Sutherland, D.E.R., Florack, G., Eisenberg, M.M., Grage, T.B.: Primary gallbladder carcinoma; Significance of subserosal lesions and results of aggressive surgical treatment and adjuvant chemotherapy. Surgery94:709, 1983
Nevin, J.E., Moran, T.J., Kay, S., King, R.: Carcinoma of the gallbladder. Staging, treatment and prognosis. Cancer37:141, 1976
Wanebo, H.J.: Hepatic and Biliary Cancer, New York, Marcel Dekker, 1987, pp. 431–445
Treadwell, T.A., Hardin, W.J.: Primary carcinoma of the gallbladder; The role of adjunctive therapy in its treatment. Am. J. Surg.132:703, 1976
Kopelson, G., Harisiadis, L., Tretter, P., Chang, C.H.: The role of radiation therapy in cancer of the extra-hepatic biliary system: An analysis of 13 patients and review of the literature of the effectiveness of surgery, chemotherapy and radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.2:883, 1977
Smoron, G.L.: Radiation therapy of carcinoma of the gallbladder and biliary tract. Cancer40:1422, 1977
Hanna, S.S., Rider W.D.: Carcinoma of the gallbladder or extrahepatic bile ducts: The role of radiotherapy. Can. Med. Assoc. J.118:59, 1978
Todoroki, T., Iwasaki, T., Okamura, T., Nagoshi, K., Asakura, H., Nishimura, A., Nakano, M., Sato, H.: Intraoperative radiation therapy for advanced carcinoma of the biliary system. Cancer46:2179, 1980
Buskirk, S.J., Gunderson, L.L., Adson, M.A., Martinez, A., May G.R., Mclerath, D.C., Nagorney, D.M., Edmundson, G.K., Bender, C.E., Martin, Jr., J.K.: Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma. Int. J. Radiation Oncol. Biol. Phys.10:2013, 1984
Bosset, J.F., Mantion, G., Gillet, M., Pelissier, E., Boulenger, M., Maingon, P., Corbion, O., Schraub, S.: Primary carcinoma of the gallbladder: Adjuvant postoperative external irradiation. Cancer64:1843, 1989
Houry, S., Schlienger, M., Huguier, M., Lacaine, F., Penne, F., Laugier, A.: Gallblaldder carcinoma: Role of radiation therapy. Br. J. Surg.76:448, 1989
Kaplan, E.L., Meier, P.: Nonparametric estimation from incomplete observation. J. Am. Stat. Assoc.53:457, 1958
Geham, E.A.: A generalized Wilcoxon test for comparing arbitarily singly-censored samples. Biometrika52:203, 1965
Piehler, J.M., Crichlow, R.W.: Primary carcinoma of the gallbladder. Surg. Gynecol. Obstet.147:929, 1978
Jönsson, P.E., Pettersson, B.A.: Carcinoma of the gallbladder—A natural history type of study. J. Surg. Oncol.21:215, 1982
Faim, R.B., McDonald, J.R., Richards, J.C., Ferris, D.O.: Carcinoma of the gallbladder; A study of its modes of spread. Ann. Surg.156:114, 1962
Ohlson, E.G., Aronsen, K.F.: Carcinoma of the gallbladlder; A study of 181 cases. Acta Chir. Scand.140:475, 1974
Starzl, T.E., Bell, R.H., Beart, R.W., Putnam, C.W.: Hepatic trisegmentectomy and other liver resections. Surg. Gynecol. Obstet.141:429, 1975
Bismuth, H., Houssin, D., and Castaing, D.: Major and minor segmentectomies “Réglées” in liver surgery. World J. Surg.6:10, 1982
Tashiro, S., Konno, T., Mochinaga, M., Nakamura, K., Murata, E., Yokoyama, I.: Treatment of carcinoma of the gallbladder in Japan. Jpn. J. Surg.12:98, 1982
Nakamura, S., Sakaguchi, S., Suzuki, S., and Muro, H.: Aggressive surgery for carcinoma of the gallbladder. Surgery106:467, 1989
Wanebo, H.J., Falkson, G., Oder, S.E.: Cancer of the hepatobiliary system. In Cancer; Principles & Practice of Oncology, 3rd edition, vol. 1, V.T. Devita, S. Hellman S.A. Rosenber, editors, New York, J.B. Lippincott, 1989, pp. 862–874
Tokoroki, T., Suit, H.D.: Therapeutic advantage in preoperative single dose radiation combined with conservative and radical surgery in different size marine fibrosarcomas. J. Surg. Oncol.29:207, 1985
Moosa, A.R., Anagnost, M., Hall, A.W., Moraldi, A., Skinner, D.B.: The continuing challenge of gallbladder cancer; Survey of thirty years' experience at the University of Chicago. Am. J. Surg.130:57, 1975
Pilepich, M.V., Lambert, P.M.: Radiotherapy of carcinomas of the extrahepatic biliary system. Radiology127:767, 1978
Fields, J.H., Emani, B.: Carcinoma of the extrahepatic biliary system—Résults of primary and adjuvant radiotherapy. Int. J. Radiation Oncol. Biol. Phys.13:331, 1987
Hishikawa, Y., Tanaka, S., Miura, T.: Radiotherapy of carcinoma of the gallbladder. Radiat. Med.1:326, 1983
Mital, B., Deutsh, M., Iwatsuki, S.: Primary cancers of extrahepatic biliary passages. Int. J. Rad. Oncol. Biol. Phys.11:849, 1985
Kopelson, G., Galdabini, J., Warshaw, A.L., Gunderson, L.L.: Patterns of failure after curative surgery for extra-hepatic biliary tract carcinoma; Implications for adjuvant therapy. Int. J. Radiat. Oncol. Biol. Phys.7:413, 1981
Author information
Authors and Affiliations
Additional information
Supported in part by Grant-in-aid for Cancer Research, No. 62-22, Ministry of Health and Welfare, Japan.
Rights and permissions
About this article
Cite this article
Todoroki, T., Iwasaki, Y., Orii, K. et al. Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma. World J. Surg. 15, 357–366 (1991). https://doi.org/10.1007/BF01658729
Issue Date:
DOI: https://doi.org/10.1007/BF01658729